The COVID-19 ASSESS-DBS Study: Mitigating the impact of COVID-19 on marginalized people through through use of dried blood spots for SARS-CoV-2 antibody testing

TEAM: Sofia Bartlett, Agatha Jassem, Vilte Barakauskas, David Goldfarb, Graham Sinclair, Paul Levett, Michelle Dittrick, Mel Krajden, Patricia Spittal, Christian Schutz, Manish Sadarangani, Danuta Skowronski, Inna Sekirov, Muhammad Morshed. COVID-19 seroprevalence studies among people who are in prison, or who work in prisons, will help us understand if our current testing approaches and policies are adequate to prevent SARS-CoV-2 transmission in these facilities. We are completing a cross-sectional study to investigate the seroprevalence of SARSCoV-2 antibodies among people who are incarcerated in British Columbia (BC) Provincial Correctional Centres, as well as staff that work in these facilities. This will be achieved by collecting Dried Blood Spot (‘DBS’) samples from 1000 voluntary participants recruited from across all 10 BC Provincial Correctional Centres, including people who are incarcerated and staff in the prisons.

BC CDC Presenters

10/14/2020 5:40:00 PM